Loading clinical trials...
Loading clinical trials...
This purpose of this study is to learn about how to provide treatment to gynecologic cancer survivors who have difficulty sleeping.
This study has two parts. In Part 1, 15 gynecologic cancer survivors will receive three candidate intervention components known to reduce sleep disturbance (i.e., sleep restriction, stimulus control, systematic light exposure) simultaneously for six weeks. Participants will then complete semi-structured individual interviews to provide feedback about barriers to and facilitators of intervention adherence. Results of Part 1 will inform the design and delivery of the candidate components in Part 2. In Part 2, a 2\^3 full factorial design will be followed to randomize 80 gynecologic cancer survivors to one of eight six-week intervention conditions reflecting all possible combinations of the three candidate intervention components.
Age
18 - No limit years
Sex
FEMALE
Healthy Volunteers
No
University of Arizona College of Nursing
Tucson, Arizona, United States
Northwestern University Feinberg School of Medicine
Chicago, Illinois, United States
Start Date
October 11, 2021
Primary Completion Date
January 31, 2026
Completion Date
January 31, 2026
Last Updated
May 1, 2025
95
ESTIMATED participants
Sleep restriction
BEHAVIORAL
Stimulus control
BEHAVIORAL
Systematic light exposure
BEHAVIORAL
Lead Sponsor
University of Arizona
Collaborators
NCT07447050
NCT07416630
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions